Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001258281.1(MSH2):c.-117G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000921 in 1,085,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
25656
American (AMR)
AF:
0.00
AC:
0
AN:
35320
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34340
South Asian (SAS)
AF:
0.00
AC:
0
AN:
72872
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33950
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3540
European-Non Finnish (NFE)
AF:
0.00000124
AC:
1
AN:
808370
Other (OTH)
AF:
0.00
AC:
0
AN:
48034
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
The c.-103G>A variant is located in the 5' untranslated region (5’ UTR) of the MSH2 gene. This variant results from a G to A substitution 103 bases upstream from the first translated codon. This nucleotide position is well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -